You’ll always know what’s going on with our organization. Just bookmark this page and check back often for the latest programs and events.
Public Meeting: Endpoints for Drug Development in Heart Failure
The Food and Drug Administration (FDA, the Agency, or we) is announcing a public workshop entitled “Endpoints for Drug Development in Heart Failure." The purpose of this public meeting is to bring the stakeholder community together to discuss clinical endpoints for trials in heart failure that could be used to support FDA approval of drugs. The workshop will focus on endpoints related to symptoms and physical function. In addition, there will be discussion of the need to assess mortality effects of drugs under development for heart failure.
